Skip to content
    Solasta Ventures logo

    Solasta Ventures

    Boston, Massachusetts, United StatesFounded 2019

    Solasta Ventures is a venture capital firm and wholly-owned subsidiary of Aju IB Investment, focused on investing in innovative companies that advance the standard of care for diseases with unmet medical needs, particularly in therapeutics and discovery platforms.

    32% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (58% of deals). Average disclosed round size is $64.9M (across 17 rounds with reported amounts).

    Find people at Solasta Ventures on Goldilocks AI

    Portfolio

    18

    Fund Size

    Top Stage

    Series B

    Last 12 Mo

    1

    Team

    Michael Jeon

    Michael Jeon

    Managing Partner

    Katlyn Gabriel

    Katlyn Gabriel

    Associate

    Derek Yoon

    Derek Yoon

    President & CEO

    Nia Julian

    Nia Julian

    Executive Assistant

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    19 investments
    CompanyRoundAmountDate
    WearLinQ logoWearLinQSeries A$14MDec 2025
    MMaxion Therapeutics Ltd.Series A$72MJan 2025
    Axonis logoAxonisSeries A$115MOct 2024
    AAxonis TherapeuticsSeries A$115MJan 2024
    Ensoma logoEnsomaSeries B$135MMay 2023
    Prime Roots logoPrime RootsSeries B$30MMay 2023
    Carbon Biosciences logoCarbon BiosciencesSeries A$38MJun 2022
    Soul Machines logoSoul MachinesSeries B$70MFeb 2022
    Immunitas Therapeutics logoImmunitas TherapeuticsSeries B$58MAug 2021
    IImmunitasSeries B$58MAug 2021
    CCarisma Therapeutics, Inc.Series BMar 2021
    IImmunitasSeries B$58MJan 2021
    RRideCell, IncSeries C$45MDec 2020
    Hotspot Therapeutics logoHotspot TherapeuticsSeries B$65MMay 2020
    ReCode Therapeutics logoReCode TherapeuticsSeries B$50M
    Exo Imaging logoExo ImagingGrowth
    Maxion logoMaxionSeries A$72M
    RReCodeSeries B$50M
    CARISMA logoCARISMASeries B$59M

    Top Co-Investors

    Last updated: 9 September 2026